Dina Radenkovic, Gameto CEO

Ex­clu­sive: Fer­til­i­ty start­up to be­gin Phase 3 study of stem cell ther­a­py for IVF

Fer­til­i­ty start­up Ga­me­to has re­ceived per­mis­sion from the FDA to see if its ovary-in-a-dish tech­nol­o­gy can make in vit­ro fer­til­iza­tion a less gru­el­ing process, the …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.